Your browser doesn't support javascript.
loading
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.
Davis, I D; Long, A; Yip, S; Espinoza, D; Thompson, J F; Kichenadasse, G; Harrison, M; Lowenthal, R M; Pavlakis, N; Azad, A; Kannourakis, G; Steer, C; Goldstein, D; Shapiro, J; Harvie, R; Jovanovic, L; Hudson, A L; Nelson, C C; Stockler, M R; Martin, A.
Afiliação
  • Davis ID; Monash University Eastern Health Clinical School, Melbourne; ANZUP Cancer Trials Group, Sydney. Electronic address: ian.davis@monash.edu.
  • Long A; ANZUP Cancer Trials Group, Sydney; NHMRC Clinical Trials Centre, University of Sydney, Sydney; Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Sydney.
  • Yip S; ANZUP Cancer Trials Group, Sydney; NHMRC Clinical Trials Centre, University of Sydney, Sydney; Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Sydney.
  • Espinoza D; ANZUP Cancer Trials Group, Sydney; NHMRC Clinical Trials Centre, University of Sydney, Sydney; Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Sydney.
  • Thompson JF; ANZUP Cancer Trials Group, Sydney; NHMRC Clinical Trials Centre, University of Sydney, Sydney.
  • Kichenadasse G; ANZUP Cancer Trials Group, Sydney; Flinders Centre for Innovation in Cancer, Flinders University, Adelaide.
  • Harrison M; ANZUP Cancer Trials Group, Sydney; Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, Sydney; Liverpool Hospital, Liverpool.
  • Lowenthal RM; ANZUP Cancer Trials Group, Sydney; Royal Hobart Hospital and Menzies Institute for Medical Research, University of Tasmania, Hobart.
  • Pavlakis N; ANZUP Cancer Trials Group, Sydney; Royal North Shore Hospital, University of Sydney, Sydney.
  • Azad A; ANZUP Cancer Trials Group, Sydney; Austin Health, Melbourne.
  • Kannourakis G; ANZUP Cancer Trials Group, Sydney; Ballarat Oncology & Haematology Services and Fiona Elsey Cancer Research Institute, Ballarat; Federation University, Ballarat.
  • Steer C; ANZUP Cancer Trials Group, Sydney; Border Medical Oncology, Wodonga.
  • Goldstein D; ANZUP Cancer Trials Group, Sydney; Prince of Wales Clinical School and Prince of Wales Hospital, University of New South Wales, Sydney.
  • Shapiro J; ANZUP Cancer Trials Group, Sydney; Cabrini Hospital, Melbourne.
  • Harvie R; ANZUP Cancer Trials Group, Sydney; Bill Walsh Translational Cancer Research Laboratories, Kolling Institute, Sydney.
  • Jovanovic L; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane.
  • Hudson AL; Bill Walsh Translational Cancer Research Laboratories, Kolling Institute, Sydney.
  • Nelson CC; ANZUP Cancer Trials Group, Sydney; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane.
  • Stockler MR; ANZUP Cancer Trials Group, Sydney; NHMRC Clinical Trials Centre, University of Sydney, Sydney; Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Sydney; Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, Sydney; Concord Cancer Centre, Concord, Australia.
  • Martin A; ANZUP Cancer Trials Group, Sydney; NHMRC Clinical Trials Centre, University of Sydney, Sydney; Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Sydney.
Ann Oncol ; 26(6): 1118-1123, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25701452
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Aged80 País/Região como assunto: Oceania Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Aged80 País/Região como assunto: Oceania Idioma: En Ano de publicação: 2015 Tipo de documento: Article